MediWound (MDWD) Enterprise Value (2013 - 2026)
MediWound (MDWD) posted quarterly Enterprise Value of -$48.3 million for Q4 2025, up 28.92% year-over-year from -$37.5 million in Q4 2024, and up 18.19% quarter-over-quarter from -$59.1 million in Q3 2025.
MediWound (MDWD) Enterprise Value (2013 - 2026) Analysis & Trends
MediWound's Enterprise Value history runs 13 years deep, the most recent figure standing at -$48.3 million for Q4 2025.
- In Q4 2025, Enterprise Value rose 28.92% year-over-year to -$48.3 million; the TTM figure through Dec 2025 stood at -$48.3 million (up 28.92% YoY), while the FY2025 annual figure was -$48.3 million, up 28.92% from the prior year.
- Enterprise Value for Q4 2025 stood at -$48.3 million, up from -$59.1 million in the prior quarter.
- The five-year high for Enterprise Value was -$9.2 million in Q1 2025, with the low at -$83.0 million in Q2 2023.
- The 5-year median for Enterprise Value is -$35.6 million (2022), against an average of -$34.2 million.
- The sharpest annual moves came in 2023 and 2024: Enterprise Value slumped 393.35% in 2023, then surged 76.74% in 2024.
- MediWound's Enterprise Value stood at -$11.0 million in 2021, then plunged by 206.85% to -$33.9 million in 2022, then slipped by 23.05% to -$41.7 million in 2023, then slumped by 63.07% to -$68.0 million in 2024, then grew by 28.92% to -$48.3 million in 2025.
- Business Quant data shows MDWD's Enterprise Value at -$48.3 million in Q4 2025, -$59.1 million in Q3 2025, and -$40.5 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -3.31 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -1.16 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 2.12 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -18.39 Bn |
| 10 | MediWound | 169.29 Mn | 138.30 Mn | 337,000.00 | -31.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -31.00 Mn |
| Dec 31, 2025 | -48.34 Mn |
| Sep 30, 2025 | -59.09 Mn |
| Jun 30, 2025 | -40.53 Mn |
| Mar 31, 2025 | -9.16 Mn |
| Dec 31, 2024 | -68.01 Mn |
| Sep 30, 2024 | -45.56 Mn |
| Jun 30, 2024 | -37.29 Mn |
| Mar 31, 2024 | -11.87 Mn |
| Dec 31, 2023 | -41.71 Mn |
| Sep 30, 2023 | -45.52 Mn |
| Jun 30, 2023 | -82.98 Mn |
| Mar 31, 2023 | -51.02 Mn |
| Dec 31, 2022 | -33.90 Mn |
| Sep 30, 2022 | -15.07 Mn |
| Jun 30, 2022 | -16.82 Mn |
| Mar 31, 2022 | -16.84 Mn |
| Dec 31, 2021 | -11.05 Mn |
| Sep 30, 2021 | -13.87 Mn |
| Jun 30, 2021 | -17.87 Mn |